Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0360220090500091404
Journal of the Korean Ophthalmological Society
2009 Volume.50 No. 9 p.1404 ~ p.1408
Effect of Bevacizumab on Survival and Production of Nitric Oxide in Trabecular Meshwork Cells
Kim Sin-Hoo

Kim Jae-Woo
Abstract
Purpose: To investigate the effect of bevacizumab, a monoclonal antibody against vascular endothelial growth factor (VEGF), on the survival and production of nitric oxide (NO) in human trabecular meshwork cells (HTMC).

Methods: Primarily cultured HTMC were exposed to 0, 0.25, 1.0, and 2.5 mg/ml bevacizumab for 24 hours. Cellular survival and production of NO were assessed by MTT assay and Griess assay, respectively.

Results: Bevacizumab did not affect the cellular survival at low concentrations but decreased cellular survival significantly at high concentrations (>1.0 mg/ml) accompanied with increased NO production.

Conclusions: High concentrations of bevacizumab may be toxic to HTMC.
KEYWORD
Bevacizumab, Nitric oxide, Trabecular meshwork cells
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø